Cargando…

Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: Health impact modelling and benefit-risk analysis

BACKGROUND: In settings where the COVID-19 vaccine supply is constrained, extending the intervals between the first and second doses of the COVID-19 vaccine may allow more people receive their first doses earlier. Our aim is to estimate the health impact of COVID-19 vaccination alongside benefit-ris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yang, Pearson, Carl A.B., Sandmann, Frank G., Barnard, Rosanna C., Kim, Jong-Hoon, Flasche, Stefan, Jit, Mark, Abbas, Kaja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996067/ https://www.ncbi.nlm.nih.gov/pubmed/35434685 http://dx.doi.org/10.1016/j.lanepe.2022.100381

Ejemplares similares

Optimising health and economic impacts of COVID-19 vaccine prioritisation strategies in the WHO European Region: a mathematical modelling study
por: Liu, Yang, et al.
Publicado: (2021)

Optimising health and economic impacts of COVID-19 vaccine prioritisation strategies in the WHO European Region
por: Liu, Yang, et al.
Publicado: (2021)

Serostatus testing and dengue vaccine cost–benefit thresholds
por: Pearson, Carl A. B., et al.
Publicado: (2019)

Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries
por: Ochalek, Jessica, et al.
Publicado: (2020)

Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis
por: Bénard, Élodie, et al.
Publicado: (2022)

Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low-income and middle-income countries: mathematical modelling and early-stage economic evaluation
por: Fu, Han, et al.
Publicado: (2023)

Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection
por: Abbas, Kaja, et al.
Publicado: (2020)

Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis
por: Bénard, Élodie, et al.
Publicado: (2023)

Safety of daily low-dose aspirin use during pregnancy in low-income and middle-income countries
por: Short, Vanessa L., et al.
Publicado: (2021)

Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings
por: Inusa, Baba Psalm Duniya, et al.
Publicado: (2018)

Multi-dose vials versus single-dose vials for vaccination: perspectives from lower-middle income countries
por: Basu, Saurav, et al.
Publicado: (2022)

The impact of prioritisation and dosing intervals on the effects of COVID-19 vaccination in Europe: an agent-based cohort model
por: Català, Martí, et al.
Publicado: (2021)

Desoxycorticosterone Pivalate Duration of Action and Individualized Dosing Intervals in Dogs with Primary Hypoadrenocorticism
por: Jaffey, J.A., et al.
Publicado: (2017)

The Potential for Reducing the Number of Pneumococcal Conjugate Vaccine Doses While Sustaining Herd Immunity in High-Income Countries
por: Flasche, Stefan, et al.
Publicado: (2015)

Not recommended fixed-dose antibiotic combinations in low- and middle-income countries – the example of Tanzania
por: Vliegenthart-Jongbloed, Klaske, et al.
Publicado: (2023)

SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling study
por: Procter, Simon R., et al.
Publicado: (2021)

SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling study
por: Procter, Simon R, et al.
Publicado: (2021)

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023)

Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules
por: Clark, Andrew, et al.
Publicado: (2019)

Extended Interval Dosing Natalizumab and impact on neuropsychological deficits in Relapsing-Remitting Multiple Sclerosis
por: McManus, Eileen J., et al.
Publicado: (2022)

Insulin prices, availability and affordability in 13 low-income and middle-income countries
por: Ewen, Margaret, et al.
Publicado: (2019)

Extended-Interval Gentamicin Dosing for Pulmonic Tularemia
por: Dietrich, Tyson, et al.
Publicado: (2019)

Pharmacodynamics of natalizumab extended interval dosing in MS
por: Zhovtis Ryerson, Lana, et al.
Publicado: (2020)

The influence of interval between doses on response to vaccines
por: Rodrigues, Charlene M.C., et al.
Publicado: (2021)

Impact of High-Dose-Rate Brachytherapy Training via Telehealth in Low- and Middle-Income Countries
por: Hatcher, Jeremy B., et al.
Publicado: (2020)

Zero-dose children and the immunisation cascade: Understanding immunisation pathways in low and middle-income countries
por: Cata-Preta, Bianca O., et al.
Publicado: (2021)

Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis
por: Prem, Kiesha, et al.
Publicado: (2023)

Mathematical Modelling Long-Term Effects of Replacing Prevnar7 with Prevnar13 on Invasive Pneumococcal Diseases in England and Wales
por: Choi, Yoon Hong, et al.
Publicado: (2012)

Point and Interval Estimators of the Target Dose in Clinical Dose-Finding Studies with Active Control
por: Helms, H.-J., et al.
Publicado: (2015)

Europe should lead in coordinated procurement of quality-assured medicines for programmes in low-income and middle-income countries
por: Perrin, Christophe, et al.
Publicado: (2020)

Stark choices: exploring health sector costs of policy responses to COVID-19 in low-income and middle-income countries
por: Torres-Rueda, Sergio, et al.
Publicado: (2021)

Interval design to identify the optimal biological dose for immunotherapy
por: Park, Yeonhee
Publicado: (2022)

Impact of time interval and dose rate on cell survival following low-dose fractionated exposures
por: Terashima, Shingo, et al.
Publicado: (2017)

Estimates of case-fatality ratios of measles in low-income and middle-income countries: a systematic review and modelling analysis
por: Portnoy, Allison, et al.
Publicado: (2019)

COVID-19's lost generation of unvaccinated children – Authors' reply
por: Abbas, Kaja, et al.
Publicado: (2021)

The middle-income trap in Central and Eastern Europe in the 2010s: institutions and divergent growth models
por: Győrffy, Dóra
Publicado: (2021)

Perceived sustainability of psychosocial treatment in low- and middle-income countries in South-Eastern Europe
por: Ribic, Emina, et al.
Publicado: (2022)

Patterns of Uveitis in the Middle East and Europe
por: Nashtaei, Ebrahim M., et al.
Publicado: (2011)

Exposure of Zero-Dose Children to Multiple Deprivation: Analyses of Data from 80 Low- and Middle-Income Countries
por: Wendt, Andrea, et al.
Publicado: (2022)

Factors associated with short birth interval in low- and middle-income countries: a systematic review
por: Pimentel, Juan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e726h6tfa674o2ohetaas7ko8h